Abviva, Inc. is a biomedical company established to develop and commercialize diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer.